Drug Trial Radar · NCT00995150
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Last checked: Nov 20, 2026Latest source record: Aug 14, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
1,910
Actual
Start
Nov 2009
Primary completion
Oct 12, 2021
Study completion Oct 12, 2021
Sponsor
- Lead sponsor
- Medicines360Academic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Oct 15, 2009
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 16 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The primary objective of this study is to assess the efficacy of a levonorgestrel-releasing intrauterine system (LNG20) in nulliparous and parous females of child-bearing potential who request long-term, reversible contraception for up to 10 years.
Conditions
- Contraception
Interventions
LNG20Drug
levonorgestrel-releasing intrauterine system for contraception
MirenaDrug
Mirena intrauterine system
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Pregnancies Per YearTime frame: 10 years
- Cumulative Pearl IndexTime frame: 8 years
Locations
25 sites in 1 country. Site status is shown where the registry gives one.
Site not named
Phoenix, Arizona
Site not named
Palo Alto, California
Site not named
San Francisco, California
Site not named
Vista, California
Site not named
Denver, Colorado
Site not named
Atlanta, Georgia
Site not named
Idaho Falls, Idaho
Site not named
Chicago, Illinois
Site not named
Des Moines, Iowa
Site not named
Ann Arbor, Michigan
Site not named
St Louis, Missouri
Site not named
New York, New York
Site not named
Chapel Hill, North Carolina
Site not named
Cincinnati, Ohio
Site not named
Cleveland, Ohio
Site not named
Columbus, Ohio
Site not named
Tulsa, Oklahoma
Site not named
Portland, Oregon
Site not named
Philadelphia, Pennsylvania
Magee Women's Hospital, University of Pittsburgh
Pittsburgh, Pennsylvania
Site not named
Dallas, Texas
Site not named
Houston, Texas
Site not named
Salt Lake City, Utah
Site not named
Norfolk, Virginia
Site not named
Seattle, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.